AU5414479A - Antitumour composition - Google Patents

Antitumour composition

Info

Publication number
AU5414479A
AU5414479A AU54144/79A AU5414479A AU5414479A AU 5414479 A AU5414479 A AU 5414479A AU 54144/79 A AU54144/79 A AU 54144/79A AU 5414479 A AU5414479 A AU 5414479A AU 5414479 A AU5414479 A AU 5414479A
Authority
AU
Australia
Prior art keywords
antitumour
composition
antitumour composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU54144/79A
Other versions
AU518952B2 (en
Inventor
Masahiko Fujii
Takayoshi Fujii
Kenichi Matsunaga
Koichi Niimura
Yoshiharu Oguchi
Chikao Yoshikumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of AU5414479A publication Critical patent/AU5414479A/en
Application granted granted Critical
Publication of AU518952B2 publication Critical patent/AU518952B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813Carrier is a saccharide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU54144/79A 1978-12-29 1979-12-21 Antitumour composition Ceased AU518952B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP16138878 1978-12-29
JP16138878A JPS5592325A (en) 1978-12-29 1978-12-29 Antitumor agent and its preparation
JP14215379 1979-11-02
JP14215279 1979-11-02

Publications (2)

Publication Number Publication Date
AU5414479A true AU5414479A (en) 1980-07-03
AU518952B2 AU518952B2 (en) 1981-10-29

Family

ID=15734135

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54144/79A Ceased AU518952B2 (en) 1978-12-29 1979-12-21 Antitumour composition

Country Status (4)

Country Link
JP (1) JPS5592325A (en)
AU (1) AU518952B2 (en)
BE (1) BE880970A (en)
ZA (1) ZA796896B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU545260B2 (en) * 1982-07-06 1985-07-04 Dow Chemical Company, The Double l-shaped electrode for brine electrolysis cell

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665828A (en) * 1979-11-02 1981-06-03 Kureha Chem Ind Co Ltd Antitumor agent
JPS58118520A (en) * 1982-01-09 1983-07-14 Hidematsu Hirai Antitumor proteinic complex and preparation thereof
JPH0651643B2 (en) * 1983-01-19 1994-07-06 帝人株式会社 Cell-killing modified immunoglobulin and method for producing the same
JPH0611713B2 (en) * 1983-04-08 1994-02-16 呉羽化学工業株式会社 Human immunoglobulin-binding antitumor agent
JPS6041617A (en) * 1983-08-18 1985-03-05 Teijin Ltd Cytocidal modified immunoglobulin and its preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS162953B1 (en) * 1972-05-10 1975-07-31
GB1509707A (en) * 1974-09-20 1978-05-04 Searle & Co Immunological compounds
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU545260B2 (en) * 1982-07-06 1985-07-04 Dow Chemical Company, The Double l-shaped electrode for brine electrolysis cell

Also Published As

Publication number Publication date
ZA796896B (en) 1980-11-26
BE880970A (en) 1980-06-30
JPS6254086B2 (en) 1987-11-13
JPS5592325A (en) 1980-07-12
AU518952B2 (en) 1981-10-29

Similar Documents

Publication Publication Date Title
AU528892B2 (en) Polymer-polyol compositions
AU6146780A (en) Rtv-silicone composition
AU4344579A (en) Nitro-bromo-alkanol compositions
AU529553B2 (en) Spraying composition
AU533436B2 (en) Anti-diarrohoea composition
AU531882B2 (en) Antiviral composition
AU5092779A (en) Polycyclic cyanoketones
AU526954B2 (en) Penicillin composition
AU5165479A (en) Substituted 1-thia-3-aza-4-ones
AU530633B2 (en) Glass composition
AU522764B2 (en) Free-expandable rubbery composition
AU526595B2 (en) Antiviral composition
AU519357B2 (en) Substituted 2-phenylimino-imidazolidines
AU531541B2 (en) Tickicidal composition
AU5399879A (en) Substituted trifluoroethylamines
AU4559679A (en) Anti-ulcer composition
AU535002B2 (en) Phosphine-releasing composition
AU4678379A (en) Substituted aklanyl-azolyl oxime-carbamates
AU518952B2 (en) Antitumour composition
AU525223B2 (en) Substituted n-acyl-amino-tetrahydro-2-furanones
AU529031B2 (en) Cephalosporin composition
AU530738B2 (en) Fasciolicidal compositions
AU525314B2 (en) Peroxydicorbonate composition
AU523867B2 (en) Substituted n-iminomethylpiperidines
AU542556B2 (en) Composition